Multiple Drug–ResistantChlamydia trachomatisAssociated with Clinical Treatment Failure
The Journal of Infectious Diseases2000Vol. 181(4), pp. 1421–1427
Citations Over TimeTop 10% of 2000 papers
Abstract
In vitro susceptibility testing and genotyping were done on urogenital isolates of Chlamydia trachomatis from 3 patients, 2 of whom showed evidence of clinical treatment failure with azithromycin and one of whom was the wife of a patient. All 3 isolates demonstrated multidrug resistance to doxycycline, azithromycin, and ofloxacin at concentrations >4.0 μg/mL. Recurrent disease due to relapsing infection with the same resistant isolate was documented on the basis of identical genotypes of both organisms. This first report of clinically significant multidrug-resistant C. trachomatis causing relapsing or persistent infection may portend an emerging problem to clinicians and public health officials.
Related Papers
- → Single dose of azithromycin for the treatment of genital chlamydial infections in adolescents(1993)50 cited
- → Ofloxacin versus doxycycline for treatment of cervical infection with Chlamydia trachomatis(1992)43 cited
- → Chlamydia treatment failure after repeat courses of azithromycin and doxycycline(2019)2 cited
- → Comparative activity of azithromycin and doxycycline against Brucella spp. infection in mice(2017)1 cited
- Ofloxacin versus doxycycline in gynecological infections.(1987)